Revvity Inc vs TKO Group Holdings Inc — how do they compare? Revvity Inc trades at $154.18 (market cap $16.98B), while TKO Group Holdings Inc trades at $178.01 (market cap $13.28B). The key difference: Revvity Inc is the larger of the two by market cap, and TKO Group Holdings Inc pays the higher dividend (1.74%). Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and TKO Group Holdings Inc for 30 Days on average.
| RVTY | TKO | |
|---|---|---|
Market Cap | $16.98B | $13.28B |
Volume | 1,456,900 | 857,653 |
Sector | Health | Media |
52-Week High | $157.36 | $224.96 |
52-Week Low | $82.26 | $175.58 |
Typical Hold Time | 12 Days | 30 Days |
Enterprise Value | $19.30B | $17.64B |
Dividend Yield | 0.18% | 1.74% |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.
The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.
TKO trades at $181.63, up 1.67% today, but technical indicators signal a bearish trend with the stock near support at $180. Fundamentally, the company shows revenue growth with 2026 revenue projected at $5.3B and net income of $230M, though its high P/E of 63.73 indicates premium valuation. Recent Q2 2026 earnings missed expectations, but the company raised full-year guidance, reflecting operational strength. A dividend of $0.79 is scheduled for payment on September 30, 2026, adding income appeal.
The outlook for TKO is mixed; strong analyst buy consensus (89.47%) and a $227 price target suggest 25% upside, driven by media rights and live events. However, risks include competitive pressures, earnings volatility, and the stock's bearish technical posture. Investors should weigh solid fundamentals against near-term price weakness and market sentiment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →